“Nivolumab, combined with standard of care trimodality therapy, appears to be promising for the treatment of grade group 5 prostate cancer," says John Michael Bryant, MD.

Video-based research in pediatric urology visits revealed high participant interest, with over 70% consent rate, highlighting the importance of communication studies. Current interpretation ...

Oliver Sartor, MD, discusses how a 70-year-old man with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) represents a typical candidate for PSMA-targeted imaging and potential ...

Optilume DCB combines mechanical dilation with paclitaxel coating for effective urethral patency maintenance in recurrent anterior urethral strictures. ROBUST III trial shows significant improvements ...

A 400 mg BID dose of oral testosterone undecanoate significantly increases serum testosterone levels and improves symptoms in hypogonadal men. The study observed decreased sex hormone binding globulin ...

IPP from Boston Scientific and Coloplast significantly increased penile length and width post-surgery compared to preoperative measurements. The study involved 151 patients, with a mean age of 64.4 ...

The "drain and retain" technique is safe for IPP revision surgeries without infection, avoiding morbidity from reservoir removal. Study across seven US centers showed similar infection rates for ...

The TRAVERSE trial is the largest randomized placebo-controlled study on testosterone therapy, impacting clinical perspectives on its risks and benefits. The study alleviates concerns about ...

MED3000 gel is FDA-cleared for over-the-counter use and improves erectile dysfunction outcomes for men and partners. A 12-week study across multiple countries showed significant improvements in SEP ...

According to iota Biosciences, the device is “designed to deliver electrical stimulation directly to the bladder wall, inducing contractions that facilitate bladder emptying in individuals impacted by ...

FSD content is scarce in urology (1.4%) and OB/GYN (5.3%) residency programs, compared to MSD content in 50% of urology programs. No urology programs included FSD curricula, while 10 of 12 OB/GYN ...

PSMA-PET imaging enables molecular-level detection of prostate cancer cells, often before CT or MRI abnormalities are visible. Sensitivity of PSMA-PET/CT in recurrent prostate cancer can reach 97% ...